Vanguard Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $100K | Buy |
|
|||||
|
2023
Q2 | $80.5K | Hold |
|
|||||
|
2023
Q1 | $51.9K | Sell |
|
|||||
|
2022
Q4 | $73.6K | Sell |
|
|||||
|
2022
Q3 | $459K | Sell |
|
|||||
|
2022
Q2 | $762K | Hold |
|
|||||
|
2022
Q1 | $1.58M | Sell |
|
|||||
|
2021
Q4 | $2.14M | Sell |
|
|||||
|
2021
Q3 | $4.97M | Sell |
|
|||||
|
2021
Q2 | $6.08M | Buy |
|
|||||
|
2021
Q1 | $3.96M | Buy |
|
|||||
|
2020
Q4 | $4.69M | Buy |
|
|||||
|
2020
Q3 | $3.06M | Sell |
|
|||||
|
2020
Q2 | $3.56M | Buy |
|
|||||
|
2020
Q1 | $2.25M | Buy |
|
|||||
|
2019
Q4 | $8.4M | Buy |
|
|||||
|
2019
Q3 | $5.14M | Buy |
|
|||||
|
2019
Q2 | $10.9M | Buy |
|
|||||
|
2019
Q1 | $11.8M | Buy |
|
|||||
|
2018
Q4 | $11.6M | Buy |
|
|||||
|
2018
Q3 | $14.6M | Buy |
|
|||||
|
2018
Q2 | $9.15M | Buy |
|